A review of the use of time‐varying covariates in the Fine‐Gray subdistribution hazard competing risk regression model

PC Austin, A Latouche, JP Fine - Statistics in medicine, 2020 - Wiley Online Library
In survival analysis, time‐varying covariates are covariates whose value can change during
follow‐up. Outcomes in medical research are frequently subject to competing risks (events …

The role of testosterone, the androgen receptor, and hypothalamic-pituitary–gonadal axis in depression in ageing Men

RL Hauger, UG Saelzler, MS Pagadala… - Reviews in Endocrine …, 2022 - Springer
Considerable research has shown that testosterone regulates many physiological systems,
modulates clinical disorders, and contributes to health outcome. However, studies on the …

[HTML][HTML] Lower urinary tract symptoms in depression: a review

DJ Anderson, A Aucoin, CR Toups… - Health psychology …, 2023 - ncbi.nlm.nih.gov
Abstract Lower Urinary Tract Symptoms (LUTS) are frequently present in the general
population as patients age with approximately a third of individuals experiencing LUTS …

Mindfulness‐based interventions for psychological wellbeing and quality of life in men with prostate cancer: A systematic review and meta‐analysis

DA Nnate, CC Anyachukwu, SE Igwe… - Psycho …, 2021 - Wiley Online Library
Abstract Objective Mindfulness‐based interventions (MBIs) are increasingly being
encouraged for managing treatment‐related symptoms but much less is known about the …

Monoamine oxidase A (MAOA): A promising target for prostate cancer therapy

H Han, H Li, Y Ma, Z Zhao, Q An, J Zhao, C Shi - Cancer Letters, 2023 - Elsevier
Monoamine oxidase A (MAOA) is a mitochondrial enzyme that catalyzes the oxidative
deamination of monoamine neurotransmitters and dietary amines. Previous studies have …

Androgen deprivation therapy and depression in the prostate cancer patients: review of risk and pharmacological management

A Alwhaibi, S Alsanea, B Almadi, J Al-Sabhan… - The Aging …, 2022 - Taylor & Francis
Purpose: Despite the effectiveness of androgen deprivation therapy in advanced prostate
cancer, serious neuropsychiatric consequences in androgen deprivation therapy (ADT) …

Prostate cancer from a sex and gender perspective: a review

MM Muermann, RJ Wassersug - Sexual Medicine Reviews, 2022 - academic.oup.com
Introduction Factors influencing patient behavior regarding risk of prostate cancer (PCa) and
outcomes of PCa treatments are poorly understood. Similarly, how PCa treatments affect …

Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis

DE Hinojosa-Gonzalez, A Zafar, G Saffati… - Prostate Cancer and …, 2024 - nature.com
Background Prostate cancer is a prevalent disease that urgently needs to address its
treatment-related complications. By examining existing evidence on the association …

Depression, anxiety, and patterns of mental health care among men with prostate cancer receiving androgen deprivation therapy

PA Tsao, RD Ross, ASB Bohnert, B Mukherjee… - The …, 2022 - academic.oup.com
Background Androgen deprivation therapy (ADT) use is associated with an increased risk of
develo** depression and anxiety. Little is known about how the mental health of these …

The mechanism of cancer-depression comorbidity

JW Huang, CA Cao, WH Zheng, CR Jia, X Liu, SQ Gao… - Neuroscience, 2024 - Elsevier
Cancer and depression are closely interrelated, particularly in patients with advanced
cancer, who often present with comorbid anxiety and depression for various reasons …